Supplements and Featured Publications
Top 8 Trials From 2021 in Breast Cancer
Volume: 01
Issue: 01
The Top 2021 Abstracts in Breast Cancer publication provides expert insights on groundbreaking abstracts in breast cancer, with a focus on HER2-positive breast cancer treatment that were presented at medical meetings throughout 2021.
Sponsored in part by Daiichi Sankyo. Content independently developed by OncLive®
SABCS 2021: Updates in HER2+ Breast Cancer
Volume: 01
Issue: 01
The SABCS 2021: Updates in HER2+ Breast Cancer publication provides expert insights on clinical news in HER2-positive breast cancer treatment from the 2021 San Antonio Breast Cancer Symposium.
Funding From Daiichi Sankyo/Content Developed Independently by OncLive
Therapeutic Considerations in Metastatic HER2+ Breast Cancer: Part 2
Volume: 1
Issue: 2
Therapeutic Considerations in Metastatic HER2+ Breast Cancer: Part 1
Volume: 1
Issue: 1
SABCS 2020: Reflections in HER2+ Breast Cancer
Volume: 1
Issue: 1
My Treatment Approach: HER2-Positive Breast Cancer
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on OncLive
1
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
Orca-T With Reduced-Intensity Conditioning Yields Robust Efficacy in Hematologic Malignancies
4
TRX103 Tr1 Cell Therapy Shows Manageable Safety and Dose-Dependent Kinetics After HLA-Mismatched HCT in Hematologic Malignancies
5